View in EDS

Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease.

Saved in:
Bibliographic Details
Title: Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease.
Authors: Soares MVD; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal., Gómez VE; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain., Azevedo RI; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal., Pereira PNG; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal., Velázquez TC; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain., Mendes L; Serviço de Imuno-Hemoterapia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., Alho AC; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., García-Guerrero E; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain., Garcia-Calderón CB; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain., Tharmaratnam K; Department of Health Data Science, University of Liverpool, Institute of Population Health, Liverpool, United Kingdom., Cabral IA; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal., Ribeiro AC; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal., Juncal C; Serviço de Imuno-Hemoterapia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., Roncon S; Serviço de Terapia Celular, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal., Pais AT; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal., Gil AR; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain., Espada E; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., Rodrigues A; Serviço de Imuno-Hemoterapia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., Garção A; Serviço de Imuno-Hemoterapia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., Yaspo ML; Max Planck Institute for Molecular Genetics, Berlin, Germany., Warnatz HJ; Max Planck Institute for Molecular Genetics, Berlin, Germany., Lehrach H; Max Planck Institute for Molecular Genetics, Berlin, Germany., Ward L; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal., Barbosa-Morais NL; Nuno Morais Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal., Quintas AM; Serviço de Oftalmologia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., Palmela P; Serviço de Estomatologia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., Caldas C; Serviço de Estomatologia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., Ferreira R; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal., Leite L; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal., Martins C; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., Lourenço F; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., Moreno R; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal., Campilho F; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal., Cheyne CP; Department of Health Data Science, University of Liverpool, Institute of Population Health, Liverpool, United Kingdom., Garcia-Fiñana M; Department of Health Data Science, University of Liverpool, Institute of Population Health, Liverpool, United Kingdom., Campos A; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal., Baron F; Division of Hematology, Department of Medicine, Centre Hospitalier Universitaire of Liège, Liège, Belgium., Arpinati M; Unit of Cellular Therapy and Hematopoietic Stem Cell Transplantation, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy., Hoffmann P; Leibniz Institute for Immunotherapy, Regensburg, Germany., Edinger M; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Department of Internal Medicine III (Hematology and Oncology), University Hospital Regensburg, Regensburg, Germany., Koreth J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA., Ritz J; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA., Vaz CP; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal., Perez-Simon JA; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain.; Department of Hematology, University Hospital Virgen del Rocio, Seville, Spain., Lacerda JF; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.
Source: Blood advances [Blood Adv] 2026 May 12; Vol. 10 (9), pp. 2904-2915.
Publication Type: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II
Journal Info: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41637631
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Soares+MVD%22">Soares MVD</searchLink>; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Gómez+VE%22">Gómez VE</searchLink>; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Azevedo+RI%22">Azevedo RI</searchLink>; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Pereira+PNG%22">Pereira PNG</searchLink>; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Velázquez+TC%22">Velázquez TC</searchLink>; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Mendes+L%22">Mendes L</searchLink>; Serviço de Imuno-Hemoterapia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Alho+AC%22">Alho AC</searchLink>; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22García-Guerrero+E%22">García-Guerrero E</searchLink>; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Calderón+CB%22">Garcia-Calderón CB</searchLink>; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Tharmaratnam+K%22">Tharmaratnam K</searchLink>; Department of Health Data Science, University of Liverpool, Institute of Population Health, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Cabral+IA%22">Cabral IA</searchLink>; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Ribeiro+AC%22">Ribeiro AC</searchLink>; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Juncal+C%22">Juncal C</searchLink>; Serviço de Imuno-Hemoterapia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Roncon+S%22">Roncon S</searchLink>; Serviço de Terapia Celular, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Pais+AT%22">Pais AT</searchLink>; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Gil+AR%22">Gil AR</searchLink>; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Espada+E%22">Espada E</searchLink>; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Rodrigues+A%22">Rodrigues A</searchLink>; Serviço de Imuno-Hemoterapia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Garção+A%22">Garção A</searchLink>; Serviço de Imuno-Hemoterapia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Yaspo+ML%22">Yaspo ML</searchLink>; Max Planck Institute for Molecular Genetics, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Warnatz+HJ%22">Warnatz HJ</searchLink>; Max Planck Institute for Molecular Genetics, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Lehrach+H%22">Lehrach H</searchLink>; Max Planck Institute for Molecular Genetics, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Ward+L%22">Ward L</searchLink>; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Barbosa-Morais+NL%22">Barbosa-Morais NL</searchLink>; Nuno Morais Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Quintas+AM%22">Quintas AM</searchLink>; Serviço de Oftalmologia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Palmela+P%22">Palmela P</searchLink>; Serviço de Estomatologia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Caldas+C%22">Caldas C</searchLink>; Serviço de Estomatologia, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Ferreira+R%22">Ferreira R</searchLink>; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Leite+L%22">Leite L</searchLink>; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Martins+C%22">Martins C</searchLink>; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Lourenço+F%22">Lourenço F</searchLink>; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Moreno+R%22">Moreno R</searchLink>; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.<br /><searchLink fieldCode="AU" term="%22Campilho+F%22">Campilho F</searchLink>; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Cheyne+CP%22">Cheyne CP</searchLink>; Department of Health Data Science, University of Liverpool, Institute of Population Health, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Garcia-Fiñana+M%22">Garcia-Fiñana M</searchLink>; Department of Health Data Science, University of Liverpool, Institute of Population Health, Liverpool, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Campos+A%22">Campos A</searchLink>; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Baron+F%22">Baron F</searchLink>; Division of Hematology, Department of Medicine, Centre Hospitalier Universitaire of Liège, Liège, Belgium.<br /><searchLink fieldCode="AU" term="%22Arpinati+M%22">Arpinati M</searchLink>; Unit of Cellular Therapy and Hematopoietic Stem Cell Transplantation, Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy.<br /><searchLink fieldCode="AU" term="%22Hoffmann+P%22">Hoffmann P</searchLink>; Leibniz Institute for Immunotherapy, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Edinger+M%22">Edinger M</searchLink>; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Department of Internal Medicine III (Hematology and Oncology), University Hospital Regensburg, Regensburg, Germany.<br /><searchLink fieldCode="AU" term="%22Koreth+J%22">Koreth J</searchLink>; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Ritz+J%22">Ritz J</searchLink>; Division of Hematologic Malignancies, Dana-Farber Cancer Institute, Boston, MA.<br /><searchLink fieldCode="AU" term="%22Vaz+CP%22">Vaz CP</searchLink>; Serviço de Transplantação de Medula Óssea, Instituto Português de Oncologia do Porto Francisco Gentil, Porto, Portugal.<br /><searchLink fieldCode="AU" term="%22Perez-Simon+JA%22">Perez-Simon JA</searchLink>; Instituto de Biomedicina de Sevilla, Instituto de Biomedicina de Sevilha (Universidad de Sevilla, Hospital Universitario Virgen del Rocío, Junta de Andalucía, Consejo Superior de Investigaciones Científicas), Seville, Spain.; Department of Hematology, University Hospital Virgen del Rocio, Seville, Spain.<br /><searchLink fieldCode="AU" term="%22Lacerda+JF%22">Lacerda JF</searchLink>; João Lacerda Lab, Gulbenkian Institute for Molecular Medicine, Lisbon, Portugal.; Faculdade de Medicina, Universidade de Lisboa, Lisbon, Portugal.; Serviço de Hematologia e Transplantação de Medula, Hospital de Santa Maria, Unidade Local de Saúde Santa Maria, Lisbon, Portugal.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101698425%22">Blood advances</searchLink> [Blood Adv] 2026 May 12; Vol. 10 (9), pp. 2904-2915.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase I; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Society+of+Hematology%22">American Society of Hematology </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101698425 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2473-9537 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2224739529%22">24739529 </searchLink><i>NLM ISO Abbreviation: </i>Blood Adv <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41637631
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1182/bloodadvances.2025017996
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2904
    Titles:
      – TitleFull: Phase 1/2 trials of donor regulatory T cells for the treatment of steroid-refractory chronic graft-versus-host disease.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Soares MVD
      – PersonEntity:
          Name:
            NameFull: Gómez VE
      – PersonEntity:
          Name:
            NameFull: Azevedo RI
      – PersonEntity:
          Name:
            NameFull: Pereira PNG
      – PersonEntity:
          Name:
            NameFull: Velázquez TC
      – PersonEntity:
          Name:
            NameFull: Mendes L
      – PersonEntity:
          Name:
            NameFull: Alho AC
      – PersonEntity:
          Name:
            NameFull: García-Guerrero E
      – PersonEntity:
          Name:
            NameFull: Garcia-Calderón CB
      – PersonEntity:
          Name:
            NameFull: Tharmaratnam K
      – PersonEntity:
          Name:
            NameFull: Cabral IA
      – PersonEntity:
          Name:
            NameFull: Ribeiro AC
      – PersonEntity:
          Name:
            NameFull: Juncal C
      – PersonEntity:
          Name:
            NameFull: Roncon S
      – PersonEntity:
          Name:
            NameFull: Pais AT
      – PersonEntity:
          Name:
            NameFull: Gil AR
      – PersonEntity:
          Name:
            NameFull: Espada E
      – PersonEntity:
          Name:
            NameFull: Rodrigues A
      – PersonEntity:
          Name:
            NameFull: Garção A
      – PersonEntity:
          Name:
            NameFull: Yaspo ML
      – PersonEntity:
          Name:
            NameFull: Warnatz HJ
      – PersonEntity:
          Name:
            NameFull: Lehrach H
      – PersonEntity:
          Name:
            NameFull: Ward L
      – PersonEntity:
          Name:
            NameFull: Barbosa-Morais NL
      – PersonEntity:
          Name:
            NameFull: Quintas AM
      – PersonEntity:
          Name:
            NameFull: Palmela P
      – PersonEntity:
          Name:
            NameFull: Caldas C
      – PersonEntity:
          Name:
            NameFull: Ferreira R
      – PersonEntity:
          Name:
            NameFull: Leite L
      – PersonEntity:
          Name:
            NameFull: Martins C
      – PersonEntity:
          Name:
            NameFull: Lourenço F
      – PersonEntity:
          Name:
            NameFull: Moreno R
      – PersonEntity:
          Name:
            NameFull: Campilho F
      – PersonEntity:
          Name:
            NameFull: Cheyne CP
      – PersonEntity:
          Name:
            NameFull: Garcia-Fiñana M
      – PersonEntity:
          Name:
            NameFull: Campos A
      – PersonEntity:
          Name:
            NameFull: Baron F
      – PersonEntity:
          Name:
            NameFull: Arpinati M
      – PersonEntity:
          Name:
            NameFull: Hoffmann P
      – PersonEntity:
          Name:
            NameFull: Edinger M
      – PersonEntity:
          Name:
            NameFull: Koreth J
      – PersonEntity:
          Name:
            NameFull: Ritz J
      – PersonEntity:
          Name:
            NameFull: Vaz CP
      – PersonEntity:
          Name:
            NameFull: Perez-Simon JA
      – PersonEntity:
          Name:
            NameFull: Lacerda JF
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 05
              Text: 2026 May 12
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2473-9537
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Blood advances
              Type: main
ResultId 1